{"id":77495,"date":"2024-05-21T21:23:15","date_gmt":"2024-05-21T19:23:15","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?page_id=77495"},"modified":"2025-06-09T16:48:38","modified_gmt":"2025-06-09T14:48:38","slug":"tmf-trend-report-2024","status":"publish","type":"page","link":"https:\/\/pantheon.veeva.com\/eu\/tmf-trend-report-2024\/","title":{"rendered":"TMF Trend Report: 7 Trends of 2024"},"content":{"rendered":"<style>\n<p>.product-container a {\n \tfont-weight:500;\n}<\/p>\n<p>p.font-20 {\n\tfont-size:20px;\n\tline-height:28px;\n}\nimg.trends {\n\tborder-radius: 12px 12px 12px 12px;\n\tbox-shadow: 4px 6px 25px 0px rgba(0, 0, 0, 0.08);\n\tmargin:12px;\n}\nimg.trends:hover {\n\tborder-radius: 12px 12px 12px 12px;\n\tbox-shadow: 4px 6px 25px 0px rgba(0, 0, 0, .16);\n}<\/p>\n<p>@media only screen and (min-width : 1200px) {\n.product-container\t.container {\n\t\twidth: 100%;\n\t\tmax-width: 1140px;\n\t}\n}<\/p>\n<p>@media only screen and (min-width : 1280px) {\n.product-container\t.container {\n\t\twidth: 100%;\n\t\tmax-width: 1180px;\n\t}\n}<\/p>\n<p>@media only screen and (min-width : 1400px) {\n.product-container\t.container {\n\t\twidth: 100%;\n\t\tmax-width: 1340px;\n\t}\n}<\/p>\n<p>ol.tmf-num  {\n\tcounter-reset: list;\n\tlist-style: none;\n\tmargin-left:25px;\n}\nol.tmf-num li {\n\tcounter-increment: list;\n\tposition: relative;\n}<\/p>\n<p>ol.tmf-num li:before {\n  \tcontent: \" \";\n  \tmargin-right: 25px;\n  \tposition: absolute;\n  \tright: 100%;\n  \tfont-size:38px;\n\tcolor:#1A76A3;\n\tfont-weight:500;\n\tmargin-top:10px;\n}\nol.tmf-num li.count1:before {\n  \tcontent: \"1\";\n}\nol.tmf-num li.count2:before {\n  \tcontent: \"2\";\n}\nol.tmf-num li.count3:before {\n  \tcontent: \"3\";\n}\nol.tmf-num li.count4:before {\n  \tcontent: \"4\";\n}\nol.tmf-num li.count5:before {\n  \tcontent: \"5\";\n}\nol.tmf-num li.count6:before {\n  \tcontent: \"6\";\n}\nol.tmf-num li.count7:before {\n  \tcontent: \"7\";\n}\n@media screen and (max-width: 991px) {\n\tol.tmf-num  {\n\t   margin-bottom:30px;\n\t}\n\tol.tmf-num li:before {\n\t\tmargin-right: 20px;\n\t\tfont-size:36px;\n\t\tmargin-top:8px;\n\t}\n}\n@media screen and (max-width: 767px) {\n\tol.tmf-num li:before {\n\t\tmargin-right: 15px;\n\t\tfont-size:32px;\n\t}\n}<\/p>\n<p>.button-default.secondary.white:hover, a.button-default.secondary.white:hover {\n\tbackground:#FF6B00;\n}<\/p>\n<\/style>\n<div class=\"single-hero\"  style=\"background-image: url('https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/05\/bg-hero_2x.png');\">\n<div class=\"container\">\n<div class=\"row flex-align text-center\">\n<div class=\"col-sm-12 col-centered \">\n<h1 class=\"mt-20\" style=\"font-weight:300;line-height:1.1em\">RPA Bots, ICH E6(R3) Updates, M&#038;A Activity: <br class=\"visible-lg\"> 7 Trends to Guide Your TMF Strategy<\/h1>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<div class=\"product-container\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-9 col-centered text-center\">\n<p class=\"strong font-20\">\n\t\t\t\tTMF leaders from top biopharma companies came together at the <a target=\"_blank\" href=\"\/events\/tmf-innovation-forum\/\" rel=\"noopener\">Veeva TMF Innovation Forum<\/a> to discuss the evolution of TMF to become a strategic function.\u00a0\n\t\t\t\t<\/p>\n<p>\n\t\t\t\tA major part of this shift will be thanks to advances in automation, like bots to automate high-volume manual activities and study scores to synthesize TMF health. These approaches will free up TMF teams to focus on high-impact initiatives, including quality control of critical documents and inspection preparation. TMF leaders can also step up to provide guidance for broader teams during organization-wide changes like M&#038;A.\n\t\t\t\t<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"row mt-40\">\n<div class=\"col-md-12\" style=\"padding:0px\">\n<h2 class=\"mb-40\">Here are seven TMF trends and how they will impact your teams:<\/h2>\n<p>\t\t\t\t<a class=\"quicklink\" href=\"#automation\"><img decoding=\"async\" class=\"trends\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/05\/automation.png\" alt=\"\" \/><\/a><br \/>\n\t\t\t\t<a class=\"quicklink\"  href=\"#study\"><img decoding=\"async\" class=\"trends\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/05\/study-health.png\" alt=\"\" \/><\/a><br \/>\n\t\t\t\t<a class=\"quicklink\" href=\"#ich\"><img decoding=\"async\" class=\"trends\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/05\/ich.png\" alt=\"\" \/><\/a><br \/>\n\t\t\t\t<a class=\"quicklink\" href=\"#inspections\"><img decoding=\"async\" class=\"trends\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/05\/inspections.png\" alt=\"\" \/><\/a><br \/>\n\t\t\t\t<a class=\"quicklink\" href=\"#outsourcing\"><img decoding=\"async\" class=\"trends\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/05\/outsourcing.png\" alt=\"\" \/><\/a><br \/>\n\t\t\t\t<a class=\"quicklink\" href=\"#data\"><img decoding=\"async\" class=\"trends\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/05\/data-standardization.png\" alt=\"\" \/><\/a><br \/>\n\t\t\t\t<a class=\"quicklink\" href=\"#ma\"><img decoding=\"async\" class=\"trends\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/05\/MA.png\" alt=\"\" \/><\/a>\n        \t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"automation\" style=\"position: absolute;top: -100px;\"><\/a>\n<\/div>\n<div class=\"product-container\" style=\"background:#f9f9f9\">\n<div class=\"container\">\n<div class=\"row text-left\">\n<div class=\"col-md-7 col-lg-8\">\n<ol class=\"tmf-num\">\n<li class=\"count1\">\n<h2 class=\"title\">Automation is reducing high-volume tasks<\/h2>\n<p>\n\t\t\t\t\t\tRobotic process automation (RPA) and other bots that automate high-volume manual activities are gaining popularity. They won\u2019t eliminate tasks that require human intervention or are subject to inspection findings. However, they will drive critical efficiencies for TMF functions.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tOne top 20 biopharma has a fleet of more than 10 bots that complete tasks like document classification, quality review, and reconciliation.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\t\u201cWe call them digital workers,\u201d says the company\u2019s head of TMF. \u201cThey have their own user IDs and system access privileges. Each bot has a TMF \u2018manager\u2019 for training and performance measurement.\u201d\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tThe company views both its human and digital workers as integral parts of its TMF strategy. The head of TMF adds: \u201cThe digital workers take care of standardized, transactional tasks while human workers focus on decision-making, defining strategy, and managing stakeholders.\u201d\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tIn four years, the company\u2019s fleet of bots has completed more than 1,000,000 transactions and saved their TMF team 200,000 hours.\n\t\t\t\t\t\t<\/p>\n<\/li>\n<\/ol><\/div>\n<div class=\"col-md-5 col-lg-4\">\n        \t<img decoding=\"async\" class=\"img-responsive mt-15\" src=\"\/wp-content\/uploads\/2024\/05\/results.png\" alt=\"\" \/>\n        \t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"study\" style=\"position: absolute;top: -100px;\"><\/a>\n<\/div>\n<div class=\"product-container\">\n<div class=\"container\">\n<div class=\"row text-left\">\n<div class=\"col-md-7 col-lg-8\">\n<ol class=\"tmf-num\">\n<li class=\"count2\">\n<h2 class=\"title\">Comprehensive study scores deliver snapshot views of TMF health<\/h2>\n<p>\n\t\t\t\t\t\tRisk-based approaches are becoming the norm for TMF management. These practices help companies improve their TMF quality by focusing effort and expenses on the highest-risk documents. For example, a company following risk-based practices can allot more time to the quality control of documents critical to inspection readiness \u2014 like a site\u2019s training record and qualifications \u2014 than to low-risk email communications with that site.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tOne large biopharma implemented risk-based reviews and created a weighted formula to assess its TMF health holistically. The formula combines quality, timeliness, and completeness metrics into a single study health score.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tThis initiative allows the company to compare study health across compounds and CROs. It also helps the company\u2019s compliance managers more effectively engage study managers to drive TMF health.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\t\u201cWe&#8217;ve seen a broader embrace of the importance of TMF,\u201d says one top 20 biopharma\u2019s TMF business operations lead. \u201cOur compliance manager is not a traffic cop who points out everything wrong with the TMF. Instead, they identify solutions.\u201d\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tSince piloting this program, the company has increased the starting TMF health score average for new studies over pilot studies by 180%. This improvement for new studies demonstrates the effectiveness of combining a risk-based approach with study health scoring.\n\t\t\t\t\t\t<\/p>\n<\/li>\n<\/ol><\/div>\n<div class=\"col-md-5 col-lg-4\">\n        \t<img decoding=\"async\" class=\"img-responsive mt-15\" src=\"\/wp-content\/uploads\/2024\/05\/health-scores.png\" alt=\"\" \/>\n        \t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"ich\" style=\"position: absolute;top: -100px;\"><\/a>\n<\/div>\n<div class=\"product-container\" style=\"background:#f9f9f9\">\n<div class=\"container\">\n<div class=\"row text-left\">\n<div class=\"col-md-7 col-lg-8\">\n<ol class=\"tmf-num\">\n<li class=\"count3\">\n<h2 class=\"title\">ICH E6(R3) is driving increased focus on risk-based TMF<\/h2>\n<p>\n\t\t\t\t\t\tICH E6(R3) is still in the works but is expected to be finalized this year. The new regulation will change how TMF teams approach data integrity, systems, and retention rules in the following ways:\n\t\t\t\t\t\t<\/p>\n<ul style=\"list-style-type: disc;\">\n<li>The regulation highlights how companies can take a more thoughtful, risk-based approach to TMF management. As the Senior Director of TMF at one large biopharma states, \u201cThe industry is shifting toward adopting a risk-based approach with ICH (E6)R3. Every organization wants to do more with less, and this model enables us to do that while driving compliance, quality, and ensuring we have successful inspection outcomes.\u201d<\/li>\n<li>It also outlines new expectations for essential or \u201cpotentially essential\u201d records. The types of records now considered potentially essential are influenced by a broader range of factors related to specific trials. This means sponsors and CROs must work together to decide what constitutes \u201cessential.\u201d<\/li>\n<li>For the first time, ICH E6(R3) explicitly introduces the role of computerized systems in clinical trials. Investigator sites will now have to ensure that their systems are \u201cfit for purpose.\u201d<\/li>\n<li>ICH E6(R3) now refers to local laws for document retention rules, which likely means that inspection sites will offload most of this responsibility onto sponsors. Consequently, sponsors will need to adapt to local regulations, potentially necessitating new processes to manage retention.<\/li>\n<\/ul>\n<p>\n\t\t\t\t\t\tICH E6(R3) will also recognize records, rather than documents, to better reflect technology use in clinical trials.\n\t\t\t\t\t\t<\/p>\n<\/li>\n<\/ol><\/div>\n<div class=\"col-md-5 col-lg-4\">\n        \t<img decoding=\"async\" class=\"img-responsive mt-15\" src=\"\/wp-content\/uploads\/2024\/05\/quote-1.png\" alt=\"\" \/>\n        \t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"inspections\" style=\"position: absolute;top: -100px;\"><\/a>\n<\/div>\n<div class=\"product-container\">\n<div class=\"container\">\n<div class=\"row text-left\">\n<div class=\"col-md-7 col-lg-8\">\n<ol class=\"tmf-num\">\n<li class=\"count4\">\n<h2 class=\"title\">Remote, hybrid, and multi-agency TMF inspections are the norm<\/h2>\n<p>\n\t\t\t\t\t\tRemote and hybrid inspections are becoming the norm, and the FDA is now teaming up with other agencies such as the EMA, MHRA, and Health Canada. In some cases, the agencies are attending one another\u2019s inspections, learning their approaches, and sharing their findings. This multi-agency approach adds layers of complexity for sponsors.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tInspectors are also asking sponsors to map the document lifecycle through sites, CROs, and ultimately their own systems. Some biopharmas are reviewing and reducing their alternate filing locations to improve document identification.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\t\u201cInspectors are more focused on the TMF \u2014 including data integrity, traceability, and audit trails \u2014 than they might have been five years ago,\u201d says one biopharma\u2019s senior director of TMF.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tThis heightened scrutiny emphasizes the importance of updating inspection-readiness processes, including audit trails.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\t\u201cRegulatory agencies are asking for remote, full user access to the eTMF system,\u201d says the head of TMF at a small biopharma. \u201cI don&#8217;t anticipate the removal of on-site inspections, but I do expect they will do a higher total number of inspections because they don\u2019t always have to be on-site.\u201d\n\t\t\t\t\t\t<\/p>\n<\/li>\n<\/ol><\/div>\n<div class=\"col-md-5 col-lg-4\">\n        \t<img decoding=\"async\" class=\"img-responsive mt-15\" src=\"\/wp-content\/uploads\/2024\/05\/increasing-global.png\" alt=\"\" \/>\n        \t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"outsourcing\" style=\"position: absolute;top: -100px;\"><\/a>\n<\/div>\n<div class=\"product-container\" style=\"background:#f9f9f9\">\n<div class=\"container\">\n<div class=\"row text-left\">\n<div class=\"col-md-7 col-lg-8\">\n<ol class=\"tmf-num\">\n<li class=\"count5\">\n<h2 class=\"title\">Biopharmas are considering tradeoffs when determining their TMF outsourcing strategies<\/h2>\n<p>\n\t\t\t\t\t\tOrganizations are looking for ways to increase their control and data ownership, including insourcing targeted areas such as medical monitoring, data management, and vendor oversight. This comes amid the industry\u2019s <a target=\"_blank\" href=\"https:\/\/www.mckinsey.com\/industries\/life-sciences\/our-insights\/cros-and-biotech-companies-fine-tuning-the-partnership\" rel=\"noopener\">pendulum swing toward insourcing<\/a>.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tHowever, sponsors should also do a cost-benefit analysis to select the right operating model because CROs lose efficiencies from automation, integration, and staff training when they work in sponsor systems. Outsourcing strategy will also drive their internal staffing numbers.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tOne top 20 biopharma is 95% insourced, with a staff of over 60 clinical documentation associates (CDA) that work with study team members and conduct quarterly meetings. \u201cThe CDAs need to think critically about what documents are needed and influence study team members to drive outcomes,\u201d says the biopharma\u2019s associate director of TMF.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tMeanwhile, another large pharma outsources significant portions of its TMF management to CROs and consulting vendors. They aim to resource one TMF lead for every 10 trials, site dependent, to drive TMF health.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\t\u201cThe role of the TMF lead is like the canary in the coal mine,\u201d says the pharma\u2019s associate director of TMF. \u201cThey help identify trends, but they&#8217;re not responsible for the content. We\u2019re pushing hard to have TMF leads identify trends and then empower business functions to address those issues.\u201d\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tEmerging biopharmas and biotechs can also consider a <a href=\"\/eu\/resources\/how-to-choose-the-right-etmf-model\/\">strategic combination of insourcing and outsourcing<\/a> \u2014 including adapting their operating model on a study-by-study basis \u2014 to drive compliance while conserving resources.\n\t\t\t\t\t\t<\/p>\n<\/li>\n<\/ol><\/div>\n<div class=\"col-md-5 col-lg-4\">\n        \t<img decoding=\"async\" class=\"img-responsive mt-15\" src=\"\/wp-content\/uploads\/2024\/05\/quote-2.png\" alt=\"\" \/>\n        \t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"data\" style=\"position: absolute;top: -100px;\"><\/a>\n<\/div>\n<div class=\"product-container\">\n<div class=\"container\">\n<div class=\"row text-left\">\n<div class=\"col-md-7 col-lg-8\">\n<ol class=\"tmf-num\">\n<li class=\"count6\">\n<h2 class=\"title\">TMF data standardization is increasing<\/h2>\n<p>\n\t\t\t\t\t\tThe TMF Reference Model is now affiliated with the Clinical Data Interchange Standards Consortium (CDISC). This signals the industry\u2019s move toward standardization and uniformity in how sponsors set up their eTMF systems, including metadata expectations.\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\t\u201cWe\u2019re very excited about this change,\u201d says one CDISC TMF Reference Model steering committee member. \u201cOne of the biggest efforts will be bringing the TMF Reference Model out of the spreadsheet and into the CDISC library.\u201d\n\t\t\t\t\t\t<\/p>\n<p>\n\t\t\t\t\t\tStandardization will improve TMF management for sponsors, particularly those that can automate processes between connected systems like eTMF and CTMS. This change will also help streamline processes for CROs as operations become more consistent across sponsor environments.\n\t\t\t\t\t\t<\/p>\n<\/li>\n<\/ol><\/div>\n<div class=\"col-md-5 col-lg-4\">\n        \t<img decoding=\"async\" class=\"img-responsive mt-15\" src=\"\/wp-content\/uploads\/2024\/05\/quote-3.png\" alt=\"\" \/>\n        \t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"ma\" style=\"position: absolute;top: -100px;\"><\/a>\n<\/div>\n<div class=\"product-container\" style=\"background:#f9f9f9\">\n<div class=\"container\">\n<div class=\"row text-left\">\n<div class=\"col-md-7 col-lg-8\">\n<ol class=\"tmf-num\">\n<li class=\"count7\">\n<h2 class=\"title\">TMF will play a bigger role in M&#038;A<\/h2>\n<p>\n\t\t\t\t\t\tTMF leaders also have numerous opportunities to provide value to their broader organizations, including during mergers and acquisitions. TMF due diligence is a critical piece of the puzzle in M&#038;A because it can:\n\t\t\t\t\t\t<\/p>\n<ul style=\"list-style-type: disc;\">\n<li>Identify hidden costs and possible filing delays for <strong>CFOs and\/or investors<\/strong><\/li>\n<li>Identify resources needed for TMF cleanup for <strong>heads of clinical operations<\/strong><\/li>\n<li>Rationalize the key data and documentation and migration strategy for <strong>IT leaders<\/strong><\/li>\n<\/ul>\n<p>\n\t\t\t\t\t\t\u201cNot assessing TMF as part of mergers and acquisitions can lead to surprises later,\u201d says one small biopharma\u2019s VP of clinical development operations. \u201cTMF leaders can impress on their company leadership why this matters and help set their companies up for success.\u201d\n\t\t\t\t\t\t<\/p>\n<\/li>\n<\/ol><\/div>\n<div class=\"col-md-5 col-lg-4\">\n        \t<img decoding=\"async\" class=\"img-responsive mt-15\" src=\"\/wp-content\/uploads\/2024\/05\/quote-4.png\" alt=\"\" \/>\n        \t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<div class=\"product-container cover\" style=\"padding:30px;background-image: url('\/wp-content\/uploads\/2024\/05\/bg-footer-cta_2x.png');\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12\">\n<h2 class=\"white mb-15\">Continue the Discussion at Veeva Summit<\/h2>\n<p class=\"white mb-30\">\n\t\t\tRegister your interest for Veeva Summit in Madrid 2025 to engage with<br \/> TMF leaders about improving trial efficiency and inspection readiness.\n\t\t\t<\/p>\n<p>\t\t\t<a href=\"\/eu\/events\/rd-summit\/register\/\" class=\"button-default secondary white mb-10\">Stay Informed<\/a>\n        \t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>From RPA bots to ICH E6(R3) updates, TMF leaders from top biopharmas share how the latest trends will guide your TMF strategy.<\/p>\n","protected":false},"author":42,"featured_media":68513,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/template-full-page.php","meta":{"footnotes":""},"coauthors":[],"class_list":["post-77495","page","type-page","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/pages\/77495"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/comments?post=77495"}],"version-history":[{"count":5,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/pages\/77495\/revisions"}],"predecessor-version":[{"id":85096,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/pages\/77495\/revisions\/85096"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/media\/68513"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=77495"}],"wp:term":[{"taxonomy":"author","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/coauthors?post=77495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}